pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-412 |
Genomic Coordinates | chr14: 101065447 - 101065537 |
Synonyms | MIRN412, hsa-mir-412, MIR412 |
Description | Homo sapiens miR-412 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-412-3p | |||||||||||||||||||||||||||||||||||||||
Sequence | 54| ACUUCACCUGGUCCACUAGCCGU |76 | |||||||||||||||||||||||||||||||||||||||
Evidence | Not_experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KCTD12 | ||||||||||||||||||||
Synonyms | C13orf2, PFET1, PFETIN | ||||||||||||||||||||
Description | potassium channel tetramerization domain containing 12 | ||||||||||||||||||||
Transcript | NM_138444 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KCTD12 | |||||||||||||||||||||
3'UTR of KCTD12 (miRNA target sites are highlighted) |
>KCTD12|NM_138444|3'UTR 1 GCTCCCCAGACCCCCTCGCCACTCCAGCGCCCAGTCCTTCTCCTGCCCGAGAGATGATTACAGAGCCTCTTGTCCCACCT 81 TTGTCCCCTGGCTGCTGCCCTCCCATTCTCCCCCTCCAGTAGTAGCTGGGTGAGACCTGTCCGCCCACCTTCCCTCCACT 161 ACAGAACCTGCAGCCGCAAATCCTCTGGGCTGCTTCGTCTTCTTTGGACCTCCTGAACCGAGAGAACCCAGAGGAACCCC 241 CACCCCACCCCCACCTACCACTCCATGCTTTCTCTACTCCCTGCCTCAAACCACCCCTCCCCCAGATGGTACTTCAGTTT 321 GGATCTATTGGGGGAGTGTGGCCACAGACCGGGGGATGATTGAATTGTTCAGAACCTGATTGGACCGTGTCCAATGTGCG 401 GAAGATTTCCTTGAAATCTTCTCAAGCTCTTATGACTCACTGGGGGTTTAAGAGATCAGGATTGGTTCCACTGTCTGGGG 481 TTAGTGTTTTACAAGGTCATTACACAGTCTTTTTGACCTCTTTTGAAGGTAGAGTTTTAGAAGGCTGGATGGAAGATTCT 561 GAGCCTGGAATTAGGACCCCATGGAGGCAGTTCAGTAACTAAACTAATAAAGTTTTGAAAAGTTACACGTAAAGTAGAAG 641 AATCTAGTGCGTGGGACAGTAAAGGATCCTTTCTCGTACAGAATAAAAGGTCTCAGCCTGTAGCTTAAACTTATAGAAAG 721 TGATCCGCCTGCCTGCAGAGGCGCCCTTTTCAGCTGCTGCTCGCCAGAAGCCCTTGATTCCACTGGTTGACATGGCAGCA 801 GTTACTGGCAAGAGGGAGAAAGGACGCTGCCGCCTAAGAGTGCAAGGCTGCTCAGGTCTCCAAGCGCCGTAGGAGGTCAC 881 CTGGCAGTGACTGTAGGGAGCTGGGTCATAGTGCACGTCGTGGGTATTAGGAAAGCCTGTATTCTTTCAATGAATGTCAG 961 TAGGACCTTCCTTTAGCTGTAAGACTTGGTGGGCGGGGTGGGGTGGGGAGGGAGGAAAGGGTAGGAAGGGTGGGAAGGGA 1041 GAAGCAGACATAGTCATTTATGATTTGAAAGTTGGAAGTTTGTACCATCTGTTTGAGTATATGCACATTTAAAAAATATC 1121 ATATAGTAAATGCAAACATGCCAAGTATTTTATAAAGATTAATAACAGACCTACTCTTACCTGGCAGTTTACTTAACTTA 1201 CTGTTTTGAGTCCTAAACTTAGAGTTGTTAATGCTTATATATAATCTAACCAAAGAGTTACCCAGTAGGGTTTTAGTTTT 1281 TGAACTTTTATTTTCTTGTTGATTATAAATCCTGATTTTGGAATCTATTGCGCAAAAGAAGTTTCATTTTGGTTACTTAG 1361 ACCTAAGATCACTTATTAAAAATCCTTATTTTCTCCAAGCCCAGCAAACGTTGACTTCTGGGCAAACCTGAAAACCTGAA 1441 AATGCCACTTTCATGCAGTTTGTTTGAAGTTAAGTGGAATCCTTTCAAATGACGAGCTGCAGAGAACTCAGCACCAAGGG 1521 CTGCCTATCTGTAGATAGCTGTAAAATGGAATATTTTTAAATGAAGGCAAATAAGTACTTAAAAGTGAGCTGAGCAATAA 1601 AATGGTCCAATAATAGGTAAATGCAACAGAAACAGAAGGAGACCTGGTTGCCTTATGCCTTTACTCTTACATGGAATAAA 1681 TTCCCAATGCATATCCTATGTAAACCATAAGTGAAGGGAAATAAACCTCGTCATGCTCCATGCTGTGAGGTGTCCTTTGG 1761 ATATTCTGTGATGACAGAGAAGCCTATTTTGTTTTGTTTTCAGCATCTTTCTCTGATGTACGTTTTTAAGGATTTTGTAA 1841 GAGCTGTTTTCAGTGTTTAAATTAGTGCTATTTTTCCTTGTTTTTAAAAATGAATCTCGTACTGTATCTTACTATGTCCA 1921 TACAGATGTTACAAATCGACAGTTTTATTCTTAGACTCATGTGATCCAAGCTGTATATACCATATATAAACATTTTACAT 2001 GAATCATTTAGTTTTTTAATTCATTTACTAATGCTATAAAATTTCCTATATTACCCCAGTAATTTGCATCAGCTGGTTTA 2081 TATACTAAAGCAACATGTTTTGATGAGTTTCTTACATCCTTATCGAGGAATTGGGTTAGGAAAAAATACATAATTGTAAA 2161 ACTGAGTTTGCTGTATTATACTTTTTTTCTTGAGTATTAGTTGTATTACTAATCATATGTTGATTAACTGTCTACTTAAA 2241 GTCAAGGTACCTGTATTTTTAATCCACTAATTTTTTTTTAGTTGGGAAATAGATTTCAGGTCTTTTATTAGACTAACATT 2321 TTTTGAGAAGTAAAATTGACTTCATATACAAAGCCTGTAATTTTAGGCGAAATGGAAGCAGAAATCTAGGAAGTTGTGCT 2401 TGCTTGTATGTTGAGTTTGGTCTCAGACTAAGTAATGCATCAGAATTCATCTGTTTGAAGCCTGAAATAATTTAGGACTC 2481 TGATTCACTGACCAAAAGTCAGTGTTGCAGAGATTTCTCTACCCCGTATGGTATTTTGTTAGATTGTTCAACAGGAAGCA 2561 CATGATTGAGAACATCTTGGGACAGACCAAAACCACTGACAGATGGCAAGGCTCGGCGATTCTGATTTCCCTTCTCAAAT 2641 CTGCTCAACTCCAAGAGTCTTGAGAAACTGCTAAAATTTTGCCTCTGTCACTCAAGTCTTACAAATGTTATCTTGTAAAC 2721 CTTTGAGGTGAACTATTCCACTGTCTTGTACATAGGCATCTTATTCACTGCACCCTGTCACACCCAGCACCCCCCGCCCC 2801 GCACATTATTTGAAAGACTGGGAATTTAATGGTTAGGGACAGTAAATCTACTTCTTTTTCCAGGGACGACTGTCCCCTCT 2881 AAAGTTAAAGTCAATACAAGAAAACTGTCTATTTTTAGCCTAAAGTAAAGGCTGTGAAGAAAATTCATTTTACATTGGGT 2961 AGACAGTAAAAAACAAGTAAAATAACTTGACATGAGCACCTTTAGATCCCTTCCCCTCCATGGGCTTTGGGCCACAGAAT 3041 GAACCTTTGAGGCCTGTAAAGTGGATTGTAATTTCCTATAAGCTGTAATAGTGGAGGTATTGTGGGTTCATTTGAGTAAG 3121 CCCTCCAAAGATACCATTCAAATAACCTGGGAGAATGTCATAAATTATTCAGATAATTAACACTGCATGAATCTGATTCA 3201 GAGGCATGCATTTACATATGTTGCCCTAATTACCATTTGATGATCATAAATACAAGTGAATGACATTGGACTTTTAGTAA 3281 CAAACTTAATTTTTAAAAAGGTGTAGACAATGGTGGTTAAAAAAAAAAAAAAAACAGGTACCAGGTTCTGTGTGTTTGCA 3361 CCAAGTAATTGACATGTTTTTTAATACATGTGGACCATGAACAGTATTCATTCTACTTTTTCAAATGATATGCTGTAGAA 3441 AATATTCCTTGAAGATGTGAGATTTAAAAATTTTTCCCTTTCAATGTTGTTATGTATTCTACTGGTTTTTGATTGATAGC 3521 ACAGTGATAAATCATAATACTAGACAAAATTGTCTTCTCTTTCAAACCAGAGCCATATATATGTCTGTATATATGGGACC 3601 TACTGCTTCTCTGAGGAAATGCATAATCTGTTAATATCAGACAAAATGAGCAATTGGCAGTGCTCATAATATATTCCAAT 3681 TTTTATTGGAATTTTCGATGGAATGTTATTTCAATAAAGCCATGTAAGGTGAAACTTTGATAACTTTTTACTCTTCAAGT 3761 TAGGGTAAATTCTGATCCAATATTCAATTCATTTGTGTACTCCCACATGCAAAATGCTAAATTACAATGCAGACATTAAG 3841 AAAAAGTATTGACTGGAGGGGTTGAATTCCTTGAGAATTTATTTTATAGTCTAAATCACAAATACTTTACTCAATTTAGT 3921 TTTTAAAATAGTAAACTGAATATTTTTGTTGTAAGCCTATCAGAGTCAATCCTTCGTTTGGAATTGTTTTCCTGTTTTTC 4001 CTTACTATAAATCATTTAAAAACTGAATTCATTTTCTTAGATGGCATAAGTCTGTCTCTTGAGAAATAAGTAAAATACTC 4081 CTATTTTCAGTATCTGTAGCACCTGAAATAGGTCTTTGTATAGCCAGAAACAAGTTATGTTGAAGTTAGCTTTTCTTTGT 4161 CAACAGTTTTGGACAATAAAAATCTGAAAGTATTAACACTTGATTTTCTACTGGGGCCCTTCAAACTTGGTTGGAAGAAA 4241 TTCAACCAGAATATCTACATTAGAGTATAATCATGTGTGGTAGGAAGATGGACTAGTTAATCAAGATTTGTTGTCACTTA 4321 AATTTTTTGTGATTTTTTTCCAAGCCAGTTTTTTTAAATTCTAAATGTGTTTTGAGGTATGGGTACATTAATTGTAATGT 4401 AAACTATTATACAACTGTTTTTGCGACTTTATAGGCAGGTAAATTTTGCTATTACTATTGAATACAAATGACAATTCATT 4481 TATGACCACTCAAACAGCGTTAGTAACCATTTAGTGACAAAGGATTAAAACATCCATCTGGATGTTAATTTTGAAGATGT 4561 AAATTATATGTTGTTTAAATTTTTCCAGGCATCTGAAAACCTTATCTGCTAGACAATGTAAGATTCACACAGAGTTATCT 4641 GGGATTCTGATTTTTTAAATAGTACATATCATTAAACCATTTTCTCTAAATGTAAGAAGAGCAGAAAAAATCTTATAAGA 4721 TTATCAGATTTTTCTAATGACACAGAAATGTAAGAAAAAAATCCCTTTATATTGAAAAAAGATGCAGTCAAAGTCTTTTC 4801 AGACATGCCCAAACTTTGAGAATTTCTTCAACCATCTAATGCTATAAAGATTTTTGTTCTTCCTGTTCACAACCAGTTGT 4881 ATAACAGAAATACTAGCTACTGTTTTCCTTCCTGTGTGTGAAGTAATGAATCATTGATTATGTGACTTGTTATGTATTCA 4961 ATTAAACACTAAAGAATAAAACATTCACTCCTTTAATTATTCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000377474.2 | 3UTR | AAAGGCUGUGAAGAAAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
138 hsa-miR-412-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT005780 | ACVR1C | activin A receptor type 1C | ![]() |
1 | 1 | |||||||
MIRT062013 | YOD1 | YOD1 deubiquitinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT345112 | ATXN7L3 | ataxin 7 like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT383735 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT396956 | CELF1 | CUGBP Elav-like family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT439280 | XIAP | X-linked inhibitor of apoptosis | ![]() |
1 | 1 | |||||||
MIRT439313 | VAT1 | vesicle amine transport 1 | ![]() |
1 | 1 | |||||||
MIRT439375 | TUBA1A | tubulin alpha 1a | ![]() |
1 | 1 | |||||||
MIRT439418 | TMOD1 | tropomodulin 1 | ![]() |
1 | 1 | |||||||
MIRT439503 | SURF4 | surfeit 4 | ![]() |
1 | 1 | |||||||
MIRT439563 | SON | SON DNA binding protein | ![]() |
1 | 1 | |||||||
MIRT439598 | SLC3A2 | solute carrier family 3 member 2 | ![]() |
1 | 1 | |||||||
MIRT439670 | SETD1B | SET domain containing 1B | ![]() |
1 | 1 | |||||||
MIRT439767 | RMND5A | required for meiotic nuclear division 5 homolog A | ![]() |
1 | 1 | |||||||
MIRT439922 | PPL | periplakin | ![]() |
1 | 1 | |||||||
MIRT439947 | PLEKHA6 | pleckstrin homology domain containing A6 | ![]() |
1 | 1 | |||||||
MIRT439952 | PLCB4 | phospholipase C beta 4 | ![]() |
1 | 1 | |||||||
MIRT439961 | PKD1 | polycystin 1, transient receptor potential channel interacting | ![]() |
1 | 1 | |||||||
MIRT440005 | PEG3 | paternally expressed 3 | ![]() |
1 | 1 | |||||||
MIRT440061 | OSBPL8 | oxysterol binding protein like 8 | ![]() |
1 | 1 | |||||||
MIRT440166 | MYH14 | myosin heavy chain 14 | ![]() |
1 | 1 | |||||||
MIRT440276 | MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | ![]() |
1 | 1 | |||||||
MIRT440437 | IPO13 | importin 13 | ![]() |
1 | 1 | |||||||
MIRT440441 | INTS3 | integrator complex subunit 3 | ![]() |
1 | 1 | |||||||
MIRT440448 | INS | insulin | ![]() |
1 | 1 | |||||||
MIRT440461 | IGF2R | insulin like growth factor 2 receptor | ![]() |
1 | 1 | |||||||
MIRT440472 | IARS | isoleucyl-tRNA synthetase | ![]() |
1 | 1 | |||||||
MIRT440530 | GUCY1A3 | guanylate cyclase 1 soluble subunit alpha | ![]() |
1 | 1 | |||||||
MIRT440542 | GOLGA2 | golgin A2 | ![]() |
1 | 1 | |||||||
MIRT440569 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
1 | 1 | |||||||
MIRT440608 | FTSJD2 | cap methyltransferase 1 | ![]() |
1 | 1 | |||||||
MIRT440750 | EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 | ![]() |
1 | 1 | |||||||
MIRT440781 | DOT1L | DOT1 like histone lysine methyltransferase | ![]() |
1 | 1 | |||||||
MIRT440804 | DNAJA4 | DnaJ heat shock protein family (Hsp40) member A4 | ![]() |
1 | 1 | |||||||
MIRT440867 | CSDE1 | cold shock domain containing E1 | ![]() |
1 | 1 | |||||||
MIRT440890 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | ![]() |
1 | 1 | |||||||
MIRT440917 | COL1A1 | collagen type I alpha 1 chain | ![]() |
1 | 1 | |||||||
MIRT440967 | CDH22 | cadherin 22 | ![]() |
1 | 1 | |||||||
MIRT440968 | CDH2 | cadherin 2 | ![]() |
1 | 1 | |||||||
MIRT441024 | CALR | calreticulin | ![]() |
1 | 1 | |||||||
MIRT441278 | ACTB | actin beta | ![]() |
1 | 1 | |||||||
MIRT448421 | TNFAIP3 | TNF alpha induced protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462833 | BCL3 | B-cell CLL/lymphoma 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465062 | TSR1 | TSR1, ribosome maturation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT476050 | GRSF1 | G-rich RNA sequence binding factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485318 | MZT1 | mitotic spindle organizing protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT493584 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT494567 | BAK1 | BCL2 antagonist/killer 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497393 | RALY | RALY heterogeneous nuclear ribonucleoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT503250 | ZNF257 | zinc finger protein 257 | ![]() |
![]() |
2 | 10 | ||||||
MIRT503656 | ZNF138 | zinc finger protein 138 | ![]() |
![]() |
2 | 10 | ||||||
MIRT505882 | RNF219 | ring finger protein 219 | ![]() |
![]() |
2 | 2 | ||||||
MIRT507525 | DSTN | destrin, actin depolymerizing factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT510663 | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT514682 | ZNF701 | zinc finger protein 701 | ![]() |
![]() |
2 | 4 | ||||||
MIRT515370 | ZNF208 | zinc finger protein 208 | ![]() |
![]() |
2 | 6 | ||||||
MIRT525237 | KCNJ12 | potassium voltage-gated channel subfamily J member 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527963 | MTAP | methylthioadenosine phosphorylase | ![]() |
![]() |
2 | 2 | ||||||
MIRT528482 | STAMBPL1 | STAM binding protein like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT529909 | C1orf64 | steroid receptor associated and regulated protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT531558 | SRD5A1 | steroid 5 alpha-reductase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532234 | KLF2 | Kruppel like factor 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT532480 | HOXA13 | homeobox A13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT535544 | P2RY2 | purinergic receptor P2Y2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547311 | NR1D2 | nuclear receptor subfamily 1 group D member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT551795 | ZNF117 | zinc finger protein 117 | ![]() |
![]() |
2 | 4 | ||||||
MIRT554939 | RAP1A | RAP1A, member of RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT558171 | EIF5A2 | eukaryotic translation initiation factor 5A2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568771 | LY6K | lymphocyte antigen 6 family member K | ![]() |
![]() |
2 | 2 | ||||||
MIRT570766 | ZNF99 | zinc finger protein 99 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572405 | MRPS14 | mitochondrial ribosomal protein S14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573396 | DLC1 | DLC1 Rho GTPase activating protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT610403 | RXRB | retinoid X receptor beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT610886 | SCN8A | sodium voltage-gated channel alpha subunit 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611197 | TMEM105 | transmembrane protein 105 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611244 | ZNF550 | zinc finger protein 550 | ![]() |
![]() |
2 | 2 | ||||||
MIRT615669 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT617974 | DOCK4 | dedicator of cytokinesis 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619150 | ZNF326 | zinc finger protein 326 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619608 | MKKS | McKusick-Kaufman syndrome | ![]() |
![]() |
2 | 2 | ||||||
MIRT621053 | DGKD | diacylglycerol kinase delta | ![]() |
![]() |
2 | 2 | ||||||
MIRT623665 | HRK | harakiri, BCL2 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT624883 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT624939 | MARCH2 | membrane associated ring-CH-type finger 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634198 | TMOD2 | tropomodulin 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT636727 | AGO2 | argonaute 2, RISC catalytic component | ![]() |
![]() |
2 | 2 | ||||||
MIRT637741 | POLR3K | RNA polymerase III subunit K | ![]() |
![]() |
2 | 2 | ||||||
MIRT638002 | ZC3H13 | zinc finger CCCH-type containing 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640395 | ZNF785 | zinc finger protein 785 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640505 | ANTXR1 | anthrax toxin receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641293 | SLAMF1 | signaling lymphocytic activation molecule family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641863 | STOML1 | stomatin like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642600 | C14orf180 | chromosome 14 open reading frame 180 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642895 | CASP1 | caspase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643967 | FHL2 | four and a half LIM domains 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT645237 | KCTD12 | potassium channel tetramerization domain containing 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646621 | CENPL | centromere protein L | ![]() |
![]() |
2 | 2 | ||||||
MIRT648620 | CYB561A3 | cytochrome b561 family member A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648908 | ZNF551 | zinc finger protein 551 | ![]() |
![]() |
2 | 2 | ||||||
MIRT649439 | HIBADH | 3-hydroxyisobutyrate dehydrogenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT650637 | LTF | lactotransferrin | ![]() |
![]() |
2 | 2 | ||||||
MIRT650971 | STARD3NL | STARD3 N-terminal like | ![]() |
![]() |
2 | 2 | ||||||
MIRT651067 | ZNF518B | zinc finger protein 518B | ![]() |
![]() |
2 | 4 | ||||||
MIRT652384 | TMEM55A | phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653958 | SEPN1 | selenoprotein N | ![]() |
![]() |
2 | 2 | ||||||
MIRT656885 | KIF1C | kinesin family member 1C | ![]() |
![]() |
2 | 2 | ||||||
MIRT657965 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658080 | FOXR2 | forkhead box R2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662570 | IL2RA | interleukin 2 receptor subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT663089 | METTL10 | EEF1A lysine methyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683705 | ZNF195 | zinc finger protein 195 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683835 | ZNF682 | zinc finger protein 682 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706811 | APOL4 | apolipoprotein L4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707575 | DYNC2LI1 | dynein cytoplasmic 2 light intermediate chain 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708606 | ZNF260 | zinc finger protein 260 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708859 | TMSB4X | thymosin beta 4, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT709861 | PDIK1L | PDLIM1 interacting kinase 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT709987 | RBM41 | RNA binding motif protein 41 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710098 | KPNA5 | karyopherin subunit alpha 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710211 | ENAH | ENAH, actin regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT710868 | B3GALNT1 | beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT710986 | SUSD5 | sushi domain containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711460 | RNF145 | ring finger protein 145 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712302 | PGM2L1 | phosphoglucomutase 2 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713609 | SYTL4 | synaptotagmin like 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713789 | MAK16 | MAK16 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT715480 | MYO9B | myosin IXB | ![]() |
![]() |
2 | 2 | ||||||
MIRT716328 | POU5F1 | POU class 5 homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717252 | TMEM246 | transmembrane protein 246 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718077 | CLIC5 | chloride intracellular channel 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718463 | EED | embryonic ectoderm development | ![]() |
![]() |
2 | 2 | ||||||
MIRT718645 | NKPD1 | NTPase KAP family P-loop domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718982 | PIGO | phosphatidylinositol glycan anchor biosynthesis class O | ![]() |
![]() |
2 | 2 | ||||||
MIRT721078 | RPS9 | ribosomal protein S9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721419 | SEC24A | SEC24 homolog A, COPII coat complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT721863 | CENPJ | centromere protein J | ![]() |
![]() |
2 | 2 | ||||||
MIRT722492 | PNKD | paroxysmal nonkinesigenic dyskinesia | ![]() |
![]() |
2 | 2 | ||||||
MIRT723391 | CALN1 | calneuron 1 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|